Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allbeevit is a vitamin B complex supplement developed and marketed by Medimet Pharmaceuticals, a pharmaceutical company based in Bangladesh. It is an oral formulation containing a therapeutically balanced combination of essential B vitamins, including thiamine (B1), riboflavin (B2), pyridoxine (B6), and niacin (B3). These vitamins serve as essential components of enzyme systems that regulate the metabolism of carbohydrates, fats, and proteins. Allbeevit is indicated for the prevention and treatment of vitamin B deficiency states, particularly in physiologically stressful conditions or when absorption is reduced. It is also used to treat specific conditions such as glossitis, stomatitis, cheilosis, and beriberi. The product is available in various oral forms, including tablets, capsules, and syrup.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Allbeevit.